You can buy or sell KROS and other stocks, options, and ETFs commission-free!
Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. Read More The company was founded in 2015 and is headquartered in Lexington, MA. The listed name for KROS is Keros Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 12, Pre-Market